Population prevalence of the MELAS A3243G mutation

Mitochondrion

Volumn 7, Issue 3, 2007, Pages 230-233

  Manwaring, Neil ^a   Jones, Michael M ^a   Wang, Jie Jin ^b   Rochtchina, Elena ^b   Howard, Chris ^a   Mitchell, Paul ^b   Sue, Carolyn M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Centre for Vision Research   (Australia)

Author keywords

Blue mountains eye study; Blue mountains hearing study; MELAS; mtDNA

Indexed keywords

ADENINE; GUANINE; MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; AUDIOLOGY; CAUCASIAN; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE MUTATION; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MELAS SYNDROME; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MALE; MELAS SYNDROME; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE;

EID: 33947278405     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2006.12.004     Document Type: Article

References (20)

1. Chinnery P.F., Wardell T.M., Singh-Kler R., Hayes C., Brown D.T., Taylor R.W., Bindoff L.A., and Turnbull D.M. The epidemiology of pathogenic mitochondrial DNA mutations. Ann. Neurol. 48 (2000) 188-193
2. Crimmins D.S., Morris J.G.L., Walker G.L., Sue C.M., Byrne E., Stevens S., Jean-Francis B., Yiannikas C., and Pamphlett R. Mitochondrial encephalomyopathy: variable clinical expression within a single kindred. J. Neurol. Neurosurg. Psychiatry 56 (1993) 900-905
3. Golding M., Mitchell P., and Cupples L. Risk markers for the graded severity of auditory processing abnormality in an older Australian population: the Blue Mountains Hearing Study. J. Am. Audiol. 16 (2005) 348-356
4. Goto Y., Nonaku I., and Horai S. A mutant in the tRNA leucine gene associated with the MELAS subgroup of mitochondrial encephalopathies. Nature 348 (1990) 651-653
5. Jones M., Mitchell P., Wang J., and Sue C.M. MELAS A3243G mitochondrial mutation and age related maculopathy. Am. J. Ophthalmol. 138 (2004) 1051-1053
6. Kadowaki T., Kadowaki H., Mori Y., Tobe K., Sakuta R., Suzuki Y., Tanabe Y., Sakura H., Awata T., Goto Y., Hayakawa T., Matsuoka K., Kawamori R., Kamada T., Horai S., Nonaka I., Hagura R., Akanuma Y., and Yazaki Y. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl. J. Med. 330 (1994) 962-968
7. Majamaa K., Moilanen J., Uimonen S., Remes A., Salmela P., Karppa M., Majamaa-Voltti K., Rusanen H., Sorri M., Peuhkurinen K., and Hassinen I. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am. J. Hum. Genet. 63 (1998) 447-454
8. Manwaring N., Jones M., Wang J., Rochtchina E., Mitchell P., and Sue C. Prevalence of mtDNA haplogroups in an Australian population. Intern. Med. J. 36 (2006) 530-533
9. McFarland R., Taylor R., and Turnbull D. The neurology of mitochondrial DNA disease. Lancet Neurol. 1 (2002) 343-351
10. Moraes C.T. Mitochondrial disorders. Curr. Opin. Neurol. 9 (1996) 369-374
11. Pavlakis S.G., Phillips P.C., DiMauro S., De Vivo D.C., and Rowland L.P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann. Neurol. 16 (1984) 481-488
12. Remes A., Karppa M., Moilanen J., Rusanen H., Hassinen I., Majamaa K., Uimonen S., Sorri M., Salmela P., Karvonen S., and Karvonen S. Epidemiology of the mitochondrial DNA 8344A>G mutation for the myoclonus epilepsy and ragged red fibres (MERRF) syndrome. J. Neurol. Neurosurg. Psychiatry 74 (2003) 1158-1159
13. Schaefer A., Taylor R., Turnbull D.M., and Chinnery P.F. The epidemiology of mitochondrial disorders-past, present and future. Biochim. Biophys. Acta 1659 (2004) 115-120
14. Sue, C.M., 1996. Diversity of phenotypic expression of patients with the MELAS 3243 point mutation. Ph.D, University of Sydney, Sydney.
15. Sue C.M., Crimmins D.S., Quigley A., Katsabanis S., Kapsa R., Byrne E., and Morris J.G.L. Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J. Neurol. Sci. 161 (1998) 36-39
16. Leu A3243G point mutation: implications for pathogenesis. J. Neurol. Neurosurg. Psychiatry 65 (1998) 233-240
17. Sue C.M., Bruno C., Andreu A.L., Cargan A., Mendell J.R., Tsao C.Y., Luquette M., Paolicchi J., Shanske S., DiMauro S., and De Vivo D.C. Infantile encephalopathy associated with the MELAS A3243G mutation. J. Pediatr. 134 (1999) 696-700
18. Sue C.M., Lipsett L.J., Crimmins D.S., Tsang C., Boyages S.C., Presgrave C.M., Gibson W.P.R., Byrne E., and Morris J.G.L. Cochlear origin of sensorineural deafness in MELAS syndrome. Ann. Neurol. 43 (1998) 350-359
19. Torroni A., Huoponen K., Francalacci P., Petrozzi M., Morelli L., Scozzari R., Obinu D., Savontaus M., and Wallace D. Classification of European mtDNAs from an analysis of three European populations. Genetics 144 (1996) 1835-1850
20. van den Ouweland J.M.W., Lemkes H.H.P.J., Trembath R.C., Ross R., Velho G., Cohen D., et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA Leu (UUR) gene. Diabetes 43 (1994) 746-751